Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Treatment after myocardial infarction]

D Beurrier1, N Danchin

  • 1Service de Cardiologie A, Hôpitaux de Brabois, CHU de Nancy, Vandoeuvre.

Presse Medicale (Paris, France : 1983)
|February 26, 1994
PubMed
Summary

Beta-blockers significantly improve survival and reduce reinfarction rates after myocardial infarction, making them essential for secondary prevention. Other treatments like calcium antagonists and antiarrhythmics show no proven benefit for post-myocardial infarction prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clusters of vascular aging manifestations predict incident cardiovascular events in the community.

Nature communications·2026
Same author

Nationwide extrapolation of economic benefit of therapeutic innovation: a 10-year retrospective budget impact of direct oral anticoagulants introduction in France.

Journal of medical economics·2025
Same author

Accelerated Vascular Aging as a Possible Mechanism of Troponin I Release in the Absence of Clinically Manifested Myocardial Injury.

Journal of the American Heart Association·2025
Same author

Obstructive sleep apnea, circulating microRNAs, and risk of cardiovascular disease.

Sleep medicine·2023
Same author

Adapted educational health program among deprived subjects with prediabetes.

Primary care diabetes·2022
Same author

A data-driven pipeline to extract potential adverse drug reactions through prescription, procedures and medical diagnoses analysis: application to a cohort study of 2,010 patients taking hydroxychloroquine with an 11-year follow-up.

BMC medical research methodology·2022

Area of Science:

  • Cardiology
  • Pharmacology

Context:

  • Myocardial infarction (MI) treatment advances necessitate effective secondary prevention strategies.
  • Beta-blockers are established antianginal agents impacting heart rate, blood pressure, and contractility.

Purpose:

  • To review the efficacy of various pharmacological and interventional treatments for secondary prevention after myocardial infarction.
  • To evaluate the impact of these treatments on mortality and reinfarction rates.

Summary:

  • Beta-blockers significantly reduce post-MI mortality (9.4% to 7.6%) and reinfarction rates (7.5% to 5.6%), proving essential for secondary prevention.
  • Calcium antagonists and Class I antiarrhythmics lack evidence for improved prognosis post-MI.
  • Angiotensin-converting enzyme inhibitors benefit select patients with heart failure, while aspirin is favored over oral anticoagulants.
  • Revascularization is indicated for symptomatic patients or those with specific risk factors; rehabilitation addresses modifiable risks.

Impact:

  • Highlights the critical role of beta-blockers in reducing cardiovascular events post-MI.
  • Provides guidance on appropriate secondary prevention strategies, emphasizing evidence-based treatments.
  • Underscores the need for individualized treatment plans based on patient symptoms and cardiac function.

Related Experiment Videos